Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)
$3.5100
-0.0200 ( -0.23% ) 0.4K
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.